| Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. | |
| | |
MedLine Citation:
|
PMID: 14752797 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Although age <1 year at diagnosis has been associated with a worse prognosis in rhabdomyosarcoma (RMS), the relationship of age at diagnosis to clinical presentation and outcome has not been evaluated carefully. We reviewed data from recent Intergroup Rhabdomyosarcoma Study Committee (later called Group, IRSG) trials to examine this relationship in order to estimate prognosis more accurately and further refine treatment. PROCEDURE: We used data from IRS-III, -IV Pilot, and -IV (1983-97, N=2,343) to study the relationship of patient age with clinical features and prognosis in a large cohort of patients treated with contemporary therapy. RESULTS: We showed that, after adjusting for important prognostic factors, age was an independent risk factor for treatment failure and patients could be classified into three failure-risk categories based on age (i.e., <1 year; 1-9 years; >10 years). Infants and adolescents were more likely to have unfavorable features, including alveolar or undifferentiated tumors and advanced Group and Stage, and also had significantly poorer failure-free survival (FFS) than did children aged 1-9 (53 and 51% vs. 72%, P<0.001). Although there was a difference in FFS among age categories, there was no evidence that age influences outcome within the three categories. CONCLUSIONS: Since age relates independently to outcome after adjustment for known risk factors, it is likely that other factors, including perhaps patients' tolerance of protocol-specified therapy, explain this relationship. |
| | |
Authors:
|
D Joshi; James R Anderson; C Paidas; J Breneman; D M Parham; W Crist; |
Related Documents
:
|
22564907 - Gender difference in age at onset of schizophrenia: a meta-analysis. 22524297 - "positive biology": the centenarian lesson. 15138717 - Expression of iap family proteins in colon cancers from patients with different age gro... 22783837 - Irritable oppositional defiance and callous unemotional traits: is the association part... 12439867 - Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: ... 15642857 - Blood pressure levels before dementia. |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Pediatric blood & cancer Volume: 42 ISSN: 1545-5009 ISO Abbreviation: Pediatr Blood Cancer Publication Date: 2004 Jan |
Date Detail:
|
Created Date: 2004-01-30 Completed Date: 2004-02-17 Revised Date: 2009-01-12 |
Medline Journal Info:
|
Nlm Unique ID: 101186624 Medline TA: Pediatr Blood Cancer Country: Unknown |
Other Details:
|
Languages: eng Pagination: 64-73 Citation Subset: IM |
Copyright Information:
|
Copyright 2003 Wiley-Liss, Inc. |
Affiliation:
|
Department of Hematology/Oncology, Nemours Children's Clinic, Orlando, Florida, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Age Factors Antineoplastic Combined Chemotherapy Protocols / therapeutic use Child Child, Preschool Clinical Trials as Topic Combined Modality Therapy Disease-Free Survival Female Humans Infant Male Prognosis Radiotherapy Rhabdomyosarcoma / diagnosis*, therapy Risk Factors Soft Tissue Neoplasms / diagnosis*, therapy Survival Rate Treatment Outcome United States / epidemiology |
| Grant Support | |
ID/Acronym/Agency:
|
CA24507/CA/NCI NIH HHS; CA72989/CA/NCI NIH HHS |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stature of young people with malignant bone tumors.
Next Document: Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncolo...